A Phase 1/2, Dose Escalation Study of Intravenous TK216 in Patients with Relapsed or Refractory Ewing Sarcoma

This Study is
No Longer Enrolling

Details
Age

Child

Type of Study

Treatment

Locations

Childrens Hospital Colorado

Study ID

Protocol Number: 16-2158

More information available at ClinicalTrials.gov: NCT02657005

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers